The argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosis
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology
Reference44 articles.
1. Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone;Hommes;Clinical Neurology and Neurosurgery,1975
2. Prognostic Factors in Intensive Immunosuppression on the Course of Chronic Progressive Multiple Sclerosis;Hommes,1980
3. Effect of intensive immunosuppression on the course of chronic progressive multiple sclerosis;Hommes;Journal of Neurology,1980
4. Short-term intensive cyclophosphamide treatment in multiple sclerosis;Theys;Journal of Neurology,1981
5. Intensive immunosuppression with cyclophosphamide in multiple sclerosis; follow-up of 110 patients for 2–6 years;Gonsette;Journal of Neurology,1977
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Late cardiotoxicity in MS patients treated with mitoxantrone;International Journal of Preventive Medicine;2019
2. Trials of Licenced RRMS DMTs in Progressive MS;Progressive Multiple Sclerosis;2017-08-11
3. Risk evaluation and monitoring in multiple sclerosis therapeutics;Multiple Sclerosis Journal;2013-11-30
4. Current Treatments for Progressive Multiple Sclerosis: Disease-Modifying Therapies;Progressive Multiple Sclerosis;2012-06-29
5. Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS;Neurology;2010-04-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3